Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9387202 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Patent 9387202 was granted and assigned to Deciphera Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Deciphera Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9387202

Date of Patent

July 12, 2016

Patent Application Number

14549125

Date Filed

November 20, 2014

Patent Citations Received

‌

US Patent 12102620 Combination therapy for the treatment of mastocytosis

‌

US Patent 12059411 Methods of treating gastrointestinal stromal tumors

‌

US Patent 12064422 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

‌

US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

‌

US Patent 11679110 Methods of treating disorders using CSF1R inhibitors

‌

US Patent 11779572 Methods of treating gastrointestinal stromal tumors

‌

US Patent 11801237 Amorphous kinase inhibitor formulations and methods of use thereof

‌

US Patent 11850241 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

...

Patent Primary Examiner

‌

James D. Anderson

Patent abstract

Compounds useful in the treatment of mammalian cancers and especially human cancers according to Formula I are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9387202 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API